- Home
- MXCT vs RMAX Comparison
MXCT vs RMAX Comparison
Compare MXCT & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- RMAX
- Stock Information
- Founded
- MXCT 1999
- RMAX 1973
- Country
- MXCT United States
- RMAX United States
- Employees
- MXCT N/A
- RMAX N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RMAX Real Estate
- Sector
- MXCT Health Care
- RMAX Finance
- Exchange
- MXCT Nasdaq
- RMAX Nasdaq
- Market Cap
- MXCT 159.9M
- RMAX 187.5M
- IPO Year
- MXCT 2021
- RMAX 2013
- Fundamental
- Price
- MXCT $1.67
- RMAX $7.71
- Analyst Decision
- MXCT Buy
- RMAX Hold
- Analyst Count
- MXCT 4
- RMAX 1
- Target Price
- MXCT $7.50
- RMAX $9.00
- AVG Volume (30 Days)
- MXCT 561.6K
- RMAX 150.3K
- Earning Date
- MXCT 11-12-2025
- RMAX 10-30-2025
- Dividend Yield
- MXCT N/A
- RMAX N/A
- EPS Growth
- MXCT N/A
- RMAX N/A
- EPS
- MXCT N/A
- RMAX 0.62
- Revenue
- MXCT $35,754,000.00
- RMAX $292,931,000.00
- Revenue This Year
- MXCT N/A
- RMAX N/A
- Revenue Next Year
- MXCT $14.72
- RMAX N/A
- P/E Ratio
- MXCT N/A
- RMAX $12.46
- Revenue Growth
- MXCT N/A
- RMAX N/A
- 52 Week Low
- MXCT $1.26
- RMAX $6.90
- 52 Week High
- MXCT $5.20
- RMAX $14.31
- Technical
- Relative Strength Index (RSI)
- MXCT 54.49
- RMAX 30.84
- Support Level
- MXCT $1.45
- RMAX $7.54
- Resistance Level
- MXCT $1.57
- RMAX $8.68
- Average True Range (ATR)
- MXCT 0.11
- RMAX 0.25
- MACD
- MXCT -0.00
- RMAX -0.06
- Stochastic Oscillator
- MXCT 71.40
- RMAX 12.78
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.